Cointime

MedTrace Pharma

company

About

MedTrace helps doctors diagnose critically ill patients faster and more accurately.

  • 1 - 10

Highlights

Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Industries
Health Care,Health Diagnostics,Life Science,Medical Device,Pharmaceutical
Founded date
Jan 5, 2015
Number Of Employee
1 - 10
Operating Status
Active

MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.

By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at the same time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
—
MedTrace Pharma has raised a total of — in funding over 2 rounds. Their latest funding was raised on May 11, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 11, 2021 Series B — 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
MedTrace Pharma is funded by 1 investors. Verve Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Verve Ventures — Series B
Cointime
Содержание
компания